[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20054148L - Nytt medikament - Google Patents

Nytt medikament

Info

Publication number
NO20054148L
NO20054148L NO20054148A NO20054148A NO20054148L NO 20054148 L NO20054148 L NO 20054148L NO 20054148 A NO20054148 A NO 20054148A NO 20054148 A NO20054148 A NO 20054148A NO 20054148 L NO20054148 L NO 20054148L
Authority
NO
Norway
Prior art keywords
new drug
zero
8alkenyl
8alkyl
thiazolyl
Prior art date
Application number
NO20054148A
Other languages
English (en)
Norwegian (no)
Inventor
Jessica Mann
Original Assignee
Speedel Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Pharma Ag filed Critical Speedel Pharma Ag
Publication of NO20054148L publication Critical patent/NO20054148L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20054148A 2003-03-06 2005-09-06 Nytt medikament NO20054148L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03100549A EP1454625A1 (en) 2003-03-06 2003-03-06 Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies
PCT/EP2004/050242 WO2004078104A2 (en) 2003-03-06 2004-03-03 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy

Publications (1)

Publication Number Publication Date
NO20054148L true NO20054148L (no) 2005-09-06

Family

ID=32799012

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054148A NO20054148L (no) 2003-03-06 2005-09-06 Nytt medikament

Country Status (27)

Country Link
US (2) US20060094731A1 (el)
EP (2) EP1454625A1 (el)
JP (1) JP4737686B2 (el)
KR (1) KR101099189B1 (el)
CN (1) CN100453081C (el)
AT (1) ATE395063T1 (el)
AU (2) AU2004216858B2 (el)
BR (1) BRPI0408082A (el)
CA (1) CA2517930C (el)
CY (1) CY1108241T1 (el)
DE (1) DE602004013734D1 (el)
DK (1) DK1601361T3 (el)
EC (1) ECSP056060A (el)
ES (1) ES2305737T3 (el)
HK (1) HK1083761A1 (el)
HR (1) HRP20050860A2 (el)
IL (1) IL170626A (el)
MX (1) MXPA05009478A (el)
NO (1) NO20054148L (el)
NZ (1) NZ542155A (el)
PL (1) PL1601361T3 (el)
PT (1) PT1601361E (el)
RS (1) RS20050683A (el)
SI (1) SI1601361T1 (el)
UA (1) UA82087C2 (el)
WO (1) WO2004078104A2 (el)
ZA (1) ZA200507122B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1595880A1 (en) * 2004-05-13 2005-11-16 Speedel Pharma AG Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists
BRPI0615794A2 (pt) * 2005-09-12 2011-05-24 Speedel Pharma Ag piridilsulfonamidil-pirimidinas para a prevenção de falha de enxerto de vaso sangüìneo
KR101967868B1 (ko) 2010-06-17 2019-08-19 닛토덴코 가부시키가이샤 신장 섬유증 치료 물질
CN109260164A (zh) * 2018-10-07 2019-01-25 威海贯标信息科技有限公司 一种阿伏生坦片剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL316259A1 (en) * 1994-03-17 1997-01-06 Ciba Geigy Ag Treatment of diabetic nephropathy with valsartan
CA2162630C (en) * 1994-11-25 2007-05-01 Volker Breu Sulfonamides
DE69626986T2 (de) * 1995-08-02 2004-02-05 Smithkline Beecham Corp. Endothelinrezeptorantagonist
US6417360B1 (en) * 1999-03-03 2002-07-09 Hoffmann-La Roche Inc. Heterocyclic sulfonamides
AU2001263850A1 (en) * 2000-04-20 2001-11-07 Actelion Pharmaceuticals Ltd Pyrimidine-sulfonamides having endothelin-antagonist activity

Also Published As

Publication number Publication date
WO2004078104A3 (en) 2004-10-28
NZ542155A (en) 2008-09-26
UA82087C2 (uk) 2008-03-11
BRPI0408082A (pt) 2006-02-14
ES2305737T3 (es) 2008-11-01
WO2004078104A2 (en) 2004-09-16
JP4737686B2 (ja) 2011-08-03
CA2517930C (en) 2011-04-26
CN100453081C (zh) 2009-01-21
RS20050683A (en) 2007-11-15
HRP20050860A2 (en) 2005-10-31
EP1601361A2 (en) 2005-12-07
AU2009225323A1 (en) 2009-11-05
AU2009225323B2 (en) 2011-11-24
KR101099189B1 (ko) 2011-12-27
DK1601361T3 (da) 2008-08-25
SI1601361T1 (sl) 2008-10-31
US20090005404A1 (en) 2009-01-01
CA2517930A1 (en) 2004-09-16
ECSP056060A (es) 2006-01-27
PT1601361E (pt) 2008-07-29
MXPA05009478A (es) 2005-10-18
EP1601361B1 (en) 2008-05-14
CN1756552A (zh) 2006-04-05
KR20050106083A (ko) 2005-11-08
AU2004216858B2 (en) 2009-07-16
JP2006519817A (ja) 2006-08-31
ZA200507122B (en) 2006-05-31
PL1601361T3 (pl) 2008-10-31
IL170626A (en) 2010-05-31
AU2004216858A1 (en) 2004-09-16
EP1454625A1 (en) 2004-09-08
HK1083761A1 (en) 2006-07-14
US20060094731A1 (en) 2006-05-04
DE602004013734D1 (de) 2008-06-26
ATE395063T1 (de) 2008-05-15
CY1108241T1 (el) 2013-09-04

Similar Documents

Publication Publication Date Title
DE60330757D1 (de) Verwendung von pyridylamiden als angiogenesehemmer
CY1112483T1 (el) Αγωνιστες gpcr πιπεριδινης
DK1855677T3 (da) 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
ATE478044T1 (de) Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c
NO20062644L (no) DPP-IV inhibitorer
NO20052796L (no) Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese
ATE540928T1 (de) Isochinolinverbindungen und ihre medizinische verwendung
CY1113171T1 (el) Αντιφλεγμονωδεις παραγοντες
BR0307894A (pt) Heterocìclos tricìclicos fundidos úteis para o tratamento de distúrbios hiperproliferativos
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
TW200728291A (en) Amide derivatives
EA200800151A1 (ru) Производные хинолина в качестве антибактериальных агентов
CY1108241T1 (el) Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειας
NO20052908D0 (no) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
GB0412314D0 (en) Compounds
SE0200198D0 (sv) New use
TW200609228A (en) Substituted n-acyl-2-aminothiazoles
ATE425162T1 (de) Thiazolderivate als npy-antagonisten
DK1924255T3 (da) Anvendelse af N-(dibenz(B,F)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamin (OMIGAPIL) til profylakse og/eller behandling af muskeldystrofi
ATE338046T1 (de) 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza- cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität
AR052553A1 (es) Derivados de benzoil -tetrahidropiridina
DK1409490T3 (da) 2-(Aminomethyl)tetrahydro-9-oxa-1,3-diazacyclopenta[a]-naphthalenylderivater med antipsykotisk virkning
TH82384A (th) อนุพันธ์แอริล 1,4-ไพราซินที่ถูกแทนที่
TH79975A (th) ยาเพื่อการรักษาหรือการป้องกันโรคภาวะพังผืด
TH76971A (th) อนุพันธ์ไตรไซคลิกที่ถูกหลอม

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application